A tissue-engineered gastric cancer model for mechanistic study of anti-tumor drugs

作者：Gao, Ming; Cai, Yiting; Wu, Wei; Shi, Yazhou; Fei, Zhewei^*

来源：Biomedical Materials (Bristol), 2013, 8(4): 045003.

DOI：10.1088/1748-6041/8/4/045003

• HUMAN TUMOR XENOGRAFTS
• STEM-CELLS
• ELECTROSPUN SCAFFOLD
• PLUS FLUOROURACIL
• MOUSE MODELS
• PHASE-III
• MICE
• OSTEOSARCOMA
• BIOMATERIALS
• CHEMOTHERAPY

The use of the traditional xenograft subcutaneous tumor model has been contested because of its limitations, such as a slow tumorigenesis, inconsistent chemotherapeutic results, etc. In light of these challenges, we aim to revamp the traditional model by employing an electrospun scaffold composed of polydioxanone, gelatin and elastin to boost the tumorigenesis. The scaffold featured a highly porous microstructure and successfully supported the growth of tumor cells in vitro without provoking apoptosis. In vivo studies showed that in the scaffold model the tumor volume increased by 43.27% and the weight by 75.58%, respectively, within a 12-week period. In addition, the scaffold model saw an increase of CD24(+) and CD44(+) cells in the tumor mass by 42% and 313%, respectively. The scaffolding materials did not lead to phenotypic changes during the tumorigenesis. Thereafter, in the scaffold model, we found that the chemotherapeutic regimen of docetaxel, cisplatin and fluorouracil unleashed a stronger capability than the regimen comprising cisplatin and fluorouracil to deplete the CD44(+) subpopulation. This discovery sheds mechanistic lights on the role of docetaxel for its future chemotherapeutic applications. This revamped model affords cancer scientists a convenient and reliable platform to mechanistically investigate the chemotherapeutic drugs on gastric cancer stem cells.

• 出版日期2013-6
• 单位上海交通大学